<code id='A934527708'></code><style id='A934527708'></style>
    • <acronym id='A934527708'></acronym>
      <center id='A934527708'><center id='A934527708'><tfoot id='A934527708'></tfoot></center><abbr id='A934527708'><dir id='A934527708'><tfoot id='A934527708'></tfoot><noframes id='A934527708'>

    • <optgroup id='A934527708'><strike id='A934527708'><sup id='A934527708'></sup></strike><code id='A934527708'></code></optgroup>
        1. <b id='A934527708'><label id='A934527708'><select id='A934527708'><dt id='A934527708'><span id='A934527708'></span></dt></select></label></b><u id='A934527708'></u>
          <i id='A934527708'><strike id='A934527708'><tt id='A934527708'><pre id='A934527708'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:fashion    Page View:3419
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In